Literature DB >> 15831915

Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

K Breitkopf1, I Sawitza, J H Westhoff, L Wickert, S Dooley, A M Gressner.   

Abstract

BACKGROUND AND AIMS: Thrombospondin 1 (TSP-1) is an important activator of latent transforming growth factor beta (TGF-beta) but little is known of the expression patterns and functions of TSP-1 in liver cells. We therefore analysed if and how TSP-1 acts on TGF-beta during fibrogenesis. METHODS AND
RESULTS: Using reverse transcription-polymerase chain reaction, we demonstrated that hepatocytes from normal liver expressed no TSP-1 mRNA whereas Kupffer cells and sinusoidal endothelial cells did. TSP-1 mRNA and protein were detected in quiescent and activated cultured hepatic stellate cells (HSC) and TSP-1 expression was highly inducible by platelet derived growth factor BB (PDGF-BB) and, to a lesser extent, by tumour necrosis factor alpha in activated HSC. Furthermore, addition of PDGF-BB directly led to enhanced TGF-beta mRNA expression and a TSP-1 dependent increase in TGF-beta/Smad signalling. Using either a peptide specifically blocking the interaction of TSP-1 with latent TGF-beta or antibodies against TSP-1 not only abrogated activation of latent TGF-beta but also reduced the effects of the active dimer itself.
CONCLUSIONS: Our data suggest that TSP-1 expression is important for TGF-beta effects and that it is regulated by the profibrogenic mediator PDGF-BB in HSC. Furthermore, the presence of TSP-1 seems to be a prerequisite for effective signal transduction by active TGF-beta not only in rat HSC but also in other cell types such as human dermal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831915      PMCID: PMC1774498          DOI: 10.1136/gut.2004.042911

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells.

Authors:  P J de Bleser; P Jannes; S C van Buul-Offers; C M Hoogerbrugge; C F van Schravendijk; T Niki; V Rogiers; J L van den Brande; E Wisse; A Geerts
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

4.  Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.

Authors:  M Okuno; K Akita; H Moriwaki; N Kawada; K Ikeda; K Kaneda; Y Suzuki; S Kojima
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

5.  Interaction of platelet-derived growth factor with thrombospondin 1.

Authors:  P J Hogg; K A Hotchkiss; B M Jiménez; P Stathakis; C N Chesterman
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription.

Authors:  C D Laherty; T M Gierman; V M Dixit
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

7.  Differential expression of thrombospondin 1, 2, and 3 during murine development.

Authors:  M L Iruela-Arispe; D J Liska; E H Sage; P Bornstein
Journal:  Dev Dyn       Date:  1993-05       Impact factor: 3.780

8.  Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo.

Authors:  Christoph Daniel; Yoshitugu Takabatake; Masayuki Mizui; Yoshitaka Isaka; Hiroshi Kawashi; Harald Rupprecht; Enyu Imai; Christian Hugo
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1.

Authors:  M J Reed; L Iruela-Arispe; E R O'Brien; T Truong; T LaBell; P Bornstein; E H Sage
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

10.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

View more
  28 in total

Review 1.  Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

Authors:  Y Inagaki; I Okazaki
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.

Authors:  Raquel López-Díez; Xiaoping Shen; Gurdip Daffu; Md Khursheed; Jiyuan Hu; Fei Song; Rosa Rosario; Yunlu Xu; Qing Li; Xiangmei Xi; Yu Shan Zou; Huilin Li; Ann Marie Schmidt; Shi Fang Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-22       Impact factor: 8.311

Review 3.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

4.  Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats.

Authors:  Shui-Xiang He; Jin-Yan Luo; Yue-Peng Wang; Yan-Li Wang; Han Fu; Jun-Li Xu; Gang Zhao; En-Qi Liu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

5.  Effect of shear stress on the migration of hepatic stellate cells.

Authors:  Toshihiro Sera; Tateki Sumii; Ryosuke Fujita; Susumu Kudo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-11-09       Impact factor: 2.416

6.  Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Authors:  Heng-Hong Li; John B Tyburski; Yi-Wen Wang; Steve Strawn; Bo-Hyun Moon; Bhaskar V S Kallakury; Frank J Gonzalez; Albert J Fornace
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

7.  Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Authors:  Jian-Jun Xie; Li-Yan Xu; Jian-Yi Wu; Zhong-Ying Shen; Qing Zhao; Ze-Peng Du; Zhuo Lv; Wei Gu; Feng Pan; Xiu-E Xu; Dong Xie; En-Min Li
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

Review 8.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

9.  PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance.

Authors:  Lata Mukundan; Justin I Odegaard; Christine R Morel; Jose E Heredia; Julia W Mwangi; Roberto R Ricardo-Gonzalez; Y P Sharon Goh; Alex Red Eagle; Shannon E Dunn; Jennifer U H Awakuni; Khoa D Nguyen; Lawrence Steinman; Sara A Michie; Ajay Chawla
Journal:  Nat Med       Date:  2009-10-18       Impact factor: 87.241

10.  Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.

Authors:  Tarik Asselah; Ivan Bièche; Ingrid Laurendeau; Michelle Martinot-Peignoux; Valerie Paradis; Dominique Vidaud; Dominique-Charles Valla; Pierre Bedossa; Patrick Marcellin; Michel Vidaud
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.